Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I, Prospective, Open Label, Multiple Dose Study Of ZYIL1 Administered Via Oral Route To Investigate The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics In Healthy Adult Subjects

NCT04972188 is registered in ClinicalTrials.gov with Zydus Lifesciences Limited as lead sponsor.

NCT NCT04972188
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04972188 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I, Prospective, Open Label, Multiple Dose Study Of ZYIL1 Administered Via Oral Route To Investigate The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics In Healthy Adult Subjects
Lead sponsor
Zydus Lifesciences Limited
Phase
Phase 1
Overall status
Completed
Start date
July 12, 2021
Completion date
October 25, 2021
Enrollment
18 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy